Edit |   |
---|---|
Antigenic Specificity | ERBB2/EGFR2/CD340 (Gancotamab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Gancotamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/EGFR2/CD340, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients). |
Immunogen | n/a |
Other Names | Gancotamab, ERBB2/EGFR2/CD340, 1509928-00-0 |
Gene, Accession # | CAS: 1509928-00-0 |
Catalog # | abx831501 |
Price | please inquire |
Order / More Info | ERBB2/EGFR2/CD340 (Gancotamab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950